Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival: Aberrant T markers on malignant plasma cells. Mediterr J Hematol Infect Dis [Internet]. 2021 Jun. 28 [cited 2026 May 2];13(1):e2021043. Available from: https://www.mjhid.org/mjhid/article/view/4616